Archive ready

新型コロナウイルスワクチンの特例承認について｜厚生労働省

https://www.mhlw.go.jp/stf/newpage_23486.html

April 4, 2026 at 03:00 AM JST•The archive page, viewer, and downloads use this saved version.

April 4, 2026 at 03:00 AM JST·www.mhlw.go.jp

The evidence pack includes HTML, screenshots, summaries, and metadata. It can be downloaded on Pro.

Saved page

新型コロナウイルスワクチンの特例承認について｜厚生労働省

Open the archived HTML with saved-time metadata attached.

Original URLhttps://www.mhlw.go.jp/stf/newpage_23486.html

StartedApril 4, 2026 at 03:00 AM JST

This HTML has CSS and images embedded, so it can still be opened even if the original page disappears.

About this pageAI generated

This page presents a press release from the Ministry of Health, Labour and Welfare dated January 21, 2022, regarding the special approval of a COVID-19 vaccine. Pfizer's "Comirnaty Intramuscular Injection for Ages 5-11" received special approval under pharmaceutical law. The vaccine is intended to prevent SARS-CoV-2 infection. The administration method involves diluting the vaccine in saline solution and administering two intramuscular injections with a three-week interval between doses.

Screenshot

The full page can be captured up to 15,000px in height so you can review the complete page layout when needed.